In multiple sclerosis, caspase-1, IL-18, and IL-1β are positively regulated in PBMCs and in mononuclear cells in the CSF during disease development, and caspase-1 expression is upregulated in demyelinating lesions [53,54]. This evidence concerns the gene CASP1 and multiple sclerosis.